Effects and mechanism of Ganoderma lucidum polysaccharides in the treatment of diabetic nephropathy in streptozotocin-induced diabetic rats
SubjectsGanoderma lucidum polysaccharides
Subject Categories::C131 Applied Cell Biology
MetadataShow full item record
AbstractGanoderma lucidum polysaccharides (GLP) have renal protection effect but there was no study on the diabetic nephropathy. This study was designed to investigate its effect and mechanism using a diabetic rat model induced by streptozotocin (50 mg/kg, i.p.). The diabetic rats were treated with GLP (300 mg/kg/day) for 10 weeks. The blood glucose, glycated hemoglobin, body weight, and the levels of blood creatinine, urea nitrogen, and urine protein were assessed. And renal pathologies were assessed by the tissue sections stained with hematoxylin-eosin, Masson’s trichome, and periodic acid-Schiff. The expression of phosphorylated phosphoinositide 3 kinase (p-PI3K), phosphorylated protein kinase B (p-Akt), and phosphorylated mammalian target of rapamycin (p-mTOR), the autophagy proteins beclin-1, LC3-II, LC3-I, and P62; the apoptosis-related proteins caspase-3 and caspase-9; and the inflammation markers IL-6, IL-1β, and TNF-ɑ were assessed. Results showed that GLP alleviated the impairment of renal function by reducing urinary protein excretion and the blood creatinine level and ameliorated diabetic nephropathy. The expression of p-PI3K, p-Akt, and p-mTOR in the diabetic kidney were significantly reduced in the GLP treatment group compared to the without treatment group. GLP treatment activated the autophagy indicators of beclin-1 and the ratio of LC3-II/LC3-I but reduced p62 and also inhibited the expression of caspase-3, caspase-9 and IL-6, IL-1β, and TNF-ɑ. In conclusion, the effect of GLP amelioration diabetic nephropathy may be via the PI3k/Akt/mTOR signaling pathway by inhibition of the apoptosis and inflammation and activation of the autophagy process.
CitationHu Y, Wang S-X, Wu F-Y, Wu K-J, Shi R-P, Qin L-H, Lu C-F, Wang S-Q, Wang F-F, Zhou S (2022) 'Effects and mechanism of Ganoderma lucidum polysaccharides in the treatment of diabetic nephropathy in streptozotocin-induced diabetic rats', BioMed Research International, 2022 (4314415)
JournalBioMed Research International
PubMed Central IDPMC8923773
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Green - can archive pre-print and post-print or publisher's version/PDF
- Dendrobium mixture attenuates renal damage in rats with diabetic nephropathy by inhibiting the PI3K/Akt/mTOR pathway.
- Authors: Chen Y, Zheng YF, Lin XH, Zhang JP, Lin F, Shi H
- Issue date: 2021 Aug
- The therapeutic prospect of zinc oxide nanoparticles in experimentally induced diabetic nephropathy.
- Authors: Abd El-Baset SA, Mazen NF, Abdul-Maksoud RS, Kattaia AAA
- Issue date: 2023 Jan 2
- Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice.
- Authors: He CY, Li WD, Guo SX, Lin SQ, Lin ZB
- Issue date: 2006 Dec
- Polysaccharides from Liriopes Radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-κB and p38 MAPK signaling pathways.
- Authors: Lu HJ, Tzeng TF, Liou SS, Da Lin S, Wu MC, Liu IM
- Issue date: 2014 May 13
- Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway.
- Authors: Nie Y, Fu C, Zhang H, Zhang M, Xie H, Tong X, Li Y, Hou Z, Fan X, Yan M
- Issue date: 2020 Oct 23